Retatrutide (Eli Lilly and Company, Indianapolis, IN, USA) is currently in phase 3 of clinical trials (TRIUMPH programme), where its antiobesity effect is being compared with placebo (NCT06383390 and NCT05929066) and with tirzepatide (NCT06662383)
Participants were genotyped using the Illumina Global Screening Array v.1.0, v.2.0 and v.2.0_EST
J ., 343 , 177-183
Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice
WADAs 2026 Prohibited List includes growth hormone releasing factors and secretagogues such as CJC-1295, Sermorelin, Tesamorelin, Ibutamoren/MK-677, and Ipamorelin
Therefore, before iron deficiency can cause severe anemia, dry and chapped lips can serve as an early warning sign